ArticleClinical oral investigations2026
Decellularized bone matrix-enriched 3D-printed GelMA scaffold as a cell-homing platform: analysis using an artificial pulp chamber model.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of the study was to develop and evaluate bio-printed hydrogels based on gelatin methacrylate (GelMA) combined with different proportions of decellularized bovine bone matrix microparticles (BMdc).
methodsGelMA hydrogels were synthesized and incorporated with decellularized bovine bone matrix (BMdc) at 1% by weight. 3D scaffolds were fabricated through extrusion, with varying infill densities (40%, 50%, and 60%), followed by photoactivation. Biological analyses included cell viability (Live/Dead assay), and proliferation (Alamar Blue assay), as well as osteogenic differentiation (ALP activity and Alizarin Red staining) over a 21-day period in HDPCs. Porosity and pore size were assessed with Rhodamine B staining, and cell migration to scaffolds was evaluated in a biomimetic artificial pulp chamber model. Data were analyzed with one-way ANOVA and Tukey’s test (p < 0.05).
resultsScaffolds with the highest porosity and the largest pore size in comparison with other groups was detected in the 40% infill group (p < 0.05). Cells in the 50% and 60% infill groups exhibited higher viability, proliferation, and osteogenic differentiation, especially when BMdc particles were incorporated (p < 0.05). The greatest cell migration at the artificial pulp chamber model was observed in the 60% infill group in association with BMdc particles (p < 0.05).
conclusionsIn summary, 3D-printed GelMA-BMdc hydrogel with 60% infill is a cytocompatible biomaterial capable of inducing cell adhesion, odontogenic differentiation, and mineralization. This innovative biomaterial shows potential for future direct pulp capping applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.